AN announcement this week by Chinese Premier, Li Ke Qiang, that China will replace the existing grace period for cross-border e-commerce with a stable policy going into the future has been warmly welcomed by Complementary Medicines Australia (CMA) ceo Carl Gibson.
Gibson said, "The Chinese Government has announced it will improve and expand the cross-border e-commerce import policy, and transform China's e-commerce rules for imported products from a transitional state to a stable one, which is very welcome news for the Australian complementary medicines industry."
Gibson went on to explain that the recent high demand for Australian products had boosted jobs in the complementary medicines sector in Australia across a range of areas, including manufacturing, scientific evaluation and research.
"In June this year, CMA hosted the very successful inaugural Australian Pavilion at the Healthplex expo in Shanghai, one of the most important expos for the preventative healthcare industry in the Asia-Pacific Region."
Gibson highlighted the ongoing potential of the industry, promising the 2019 Australian Pavilion for Healthplex would triple in size.
The above article was sent to subscribers in Pharmacy Daily's issue from 23 Nov 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 23 Nov 18
